Teva’S Emrusolmin Granted U.S. FDA Fast Track Designation For Treatment Of Multiple System Atrophy
RefinitivMenos de 1 minuto de leitura
Teva Pharmaceutical Industries Ltd 
TEVA:
TEVA’S EMRUSOLMIN GRANTED U.S. FDA FAST TRACK DESIGNATION FOR TREATMENT OF MULTIPLE SYSTEM ATROPHY
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Entrar ou criar uma conta gratuita para ler essa notícia